Clinical Scorecard: Cannabis Use During the Perioperative Period in Bariatric Surgery Patients: An Analysis of Results and Suggested Management Pathway
At a Glance
Category
Detail
Condition
Cannabis use in bariatric surgery patients
Key Mechanisms
THC acts as a partial agonist at CB1 and CB2 receptors affecting mood, memory, motor control, and cardiovascular function; CBD interacts with serotonin 1A receptors influencing analgesia and inflammation
Target Population
Patients undergoing bariatric surgery who use cannabis
Care Setting
Perioperative setting including preoperative evaluation and surgical care
Key Highlights
Cannabis use is reported in 6–8% of bariatric surgery patients and may impact perioperative outcomes.
THC has dose-dependent cardiovascular effects: acute low doses cause hypertension and tachycardia; chronic high doses may cause hypotension and bradycardia.
Anesthesia guidelines recommend avoiding cannabinoids within 72 hours before surgery due to increased perioperative myocardial infarction risk.
Guideline-Based Recommendations
Diagnosis
Screen bariatric surgery candidates for cannabis use and cannabis use disorder during preoperative evaluation.
Assess substance use history comprehensively given the risk of substance use disorders postoperatively.
Management
Avoid cannabinoids at least 72 hours prior to surgery to reduce perioperative cardiac risks.
Employ a multidisciplinary approach including nutritional, psychosocial, and medical evaluations to optimize surgical outcomes.
No standardized guidelines exist; clinical pathways should be individualized considering legal status and patient use patterns.
Monitoring & Follow-up
Monitor cardiovascular status closely perioperatively due to risk of myocardial infarction and arrhythmias.
Observe respiratory function intra- and postoperatively given cannabis-related pulmonary alterations.
Risks
Increased risk of perioperative myocardial infarction (OR 1.88) associated with cannabis use.
Potential amplified risk of arrhythmias in obese patients using cannabis, though not yet studied.
Altered anesthetic requirements and respiratory physiology due to cannabis effects.
Patient & Prescribing Data
Bariatric surgery candidates with reported cannabis use
Cannabis use may complicate perioperative management; avoidance prior to surgery is advised to mitigate cardiovascular and respiratory risks.
Clinical Best Practices
Incorporate detailed substance use screening including cannabis during preoperative assessments.
Educate patients on potential perioperative risks associated with cannabis use.
Coordinate care with anesthesia and surgical teams to plan timing of surgery relative to cannabis cessation.
Use a multidisciplinary team to address co-morbidities and optimize patient readiness for surgery.
A large audit of biomedical publications suggests fabricated references are increasingly appearing in peer-reviewed papers — often in ways that are difficult for reviewers and readers to detect.
